What’s Next? Five Things To Look Out For In September
Key Vascepa Appeal Kicks Off
Executive Summary
In September, Dr Reddy’s and Hikma will brace themselves for the beginning of Amarin’s appeal over its Vascepa (icosapent ethyl) patent-litigation defeat, while the final financial results for the 30 June quarter and year-end will trickle in.